Check out our latest paper! Out now in Genome Biology! Many thanks to all coauthors for their invaluable contributions on this lengthy journey pubmed.ncbi.nlm.nih.gov/40346709/

Check out our latest paper! WGS on 378 metastases of patients with prostate cancer. Biggest findings: 1. Non-coding mutations converge on DNA damage repair 2. Coding mutations defer between metastatic sites, with potential implications on systemic therapy selection. pubmed.ncbi.nlm.nih.gov/40114169/

Check out our latest preprint! Interested in Androgen Receptor, gene regulation and TRIM proteins? Well, in that case, I believe you’ll like this story! www.biorxiv.org/content/10.1...

What do steroid hormone receptor action and DNA damage repair have in common? Check out our latest review in @cp-trendsmolecmed.bsky.social! pubmed.ncbi.nlm.nih.gov/39934021/

🌟 Spots are limited—register now! 🌟 Join us for the 2025 Cancer Genetics and Epigenetics GRC in Tuscany, Italy, May 18–23, where global experts will present their latest breakthroughs and discuss the future of cancer research. Register today: www.grc.org/cancer-genet...

Looking forward visiting @inem-necker.bsky.social and @goffinlab.bsky.social! Great day of talking science and meeting scientists in the beautiful city of Paris; whats not to like? 😁

I'm pleased to announce that the ASCO/Conquer Cancer Foundation Felix Feng Prostate Cancer YIA is now fully endowed and will fund a young prostate cancer investigator every year, in perpetuity. The First Felix Feng YIA recipient will be announced this spring and celebrated at ASCO's annual meeting.

In Memory of Dr Felix Feng, our beloved friend and a giant in prostate cancer @ericsmall.bsky.social @ucsfcancer.bsky.social www.sciencedirect.com/science/arti...